You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim

Last Updated: February 26, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Bapineuzumab

Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

What is the drug development status for Bapineuzumab?

Bapineuzumab is an investigational drug.

There have been 14 clinical trials for Bapineuzumab. The most recent clinical trial was a Phase 3 trial, which was initiated on December 1st 2007.

The most common disease conditions in clinical trials are Alzheimer Disease and [disabled in preview]. The leading clinical trial sponsors are Pfizer, JANSSEN Alzheimer Immunotherapy Research & Development, LLC, and Wyeth is now a wholly owned subsidiary of Pfizer.

Recent Clinical Trials for Bapineuzumab
Retrieval of Patient Information After DiscontinuationPfizerN/A
Retrieval of Patient Information After DiscontinuationJANSSEN Alzheimer Immunotherapy Research & Development, LLCN/A
Amyloid Imaging And Safety Study Of Subcutaneous Bapineuzumab In Subjects With Mild to Moderate Alzheimer's DiseasePfizerPhase 2

See all Bapineuzumab clinical trials

Clinical Trial Summary for Bapineuzumab

Top disease conditions for Bapineuzumab
Top clinical trial sponsors for Bapineuzumab

See all Bapineuzumab clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.